[1] Cao XB, Wu ZY. Methadone maintenance treatment as an HIV prevention strategy: a research update. China J STD/AIDS, 2011; 17, 196−9. (In Chinese
[2] Cao XB, Lin CQ, Wang CH, et al. The national methadone maintenance treatment program. In: Wu ZY, Wang Y, Detels R, et al. HIV/AIDS in China. Springer, 2020; 177−200.
[3] WHO, UNODC, UNAIDS. WHO/UNODC/UNAIDS Position Paper: Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention. Geneva: WHO, 2004.
[4] Cao XB, Wu ZY, Rou KM, et al. Retention and its predictors among methadone maintenance treatment clients in China: a six-year cohort study. Drug Alcohol Depend, 2014; 145, 87−93. doi:  10.1016/j.drugalcdep.2014.09.776
[5] Xu JS, Huan XP, Yang HT, et al. Survey on drug abuse among patients on methadone maintenance treatment in Jiangsu Province. Chin J Drug Depend, 2009; 18, 424−7. (In Chinese
[6] Peles E, Adelson M, Schreiber S. Benzodiazepine usage during 19.5 years in methadone maintenance treatment patients and its relation to long-term outcome. Isr J Psychiatry Relat Sci, 2014; 51, 285−8.
[7] Brands B, Blake J, Marsh DC, et al. The impact of benzodiazepine use on methadone maintenance treatment outcomes. J Addict Dis, 2008; 27, 37−48.
[8] Mark TL, Dilonardo J, Vandivort R, et al. Psychiatric and medical comorbidities, associated pain, and health care utilization of patients prescribed buprenorphine. J Subst Abuse Treat, 2013; 44, 481−7. doi:  10.1016/j.jsat.2012.11.004
[9] White WL, Campbell MD, Spencer RD, et al. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention. J Psychoactive Drugs, 2014; 46, 114−22. doi:  10.1080/02791072.2014.901587
[10] Herdener M, Dürsteler KM, Seifritz E, et al. Changes in substance use in patients receiving opioid substitution therapy and resulting clinical challenges: a 17-year treatment case register analysis. Lancet Psychiatry, 2017; 4, 302−9. doi:  10.1016/S2215-0366(17)30080-9